http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10842311

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 289
issn 0223-5234
pageRange 276-289
publicationName European Journal of Medicinal Chemistry
startingPage 276
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_82f7f69109f6ba1ec9f38470c1199339
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_84e84add41ed72368505408a94f1059f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd23225bb8277d80089ba14432de98d3
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0352fa9dbf5677f98c9a97bb83d9d515
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ccbd4c488d5e1508f7179d1352a72ba5
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9ecd1e760ca7f5206dfb519249a02633
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2804252c8eed44176b9c096bcb468a98
bibliographicCitation Stepanek O, Hin N, Thomas AG, Dash RP, Alt J, Rais R, Rojas C, Slusher BS, Tsukamoto T. Neutral sphingomyelinase 2 inhibitors based on the 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol scaffold. European Journal of Medicinal Chemistry. 2019 May;170():276–89. doi: 10.1016/j.ejmech.2019.03.015.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a4f57890719ecb9bd9ec599c07f416f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0216-7520
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8878d783de56d183f87e279107082e5c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48de6871139e9916cb9808f940702245
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_734aa85636afe38158b88f0e6a0d83b8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_abc2f4c02635087bb39da2eb9f14ac0b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41a850e8ad7308005e1c3b9f3b025c1e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc0961012c20897d1e22050638ca31a1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b6aaa8772527458bb6a8c50a5967968
date 2019-05-15^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/30921693
https://pubmed.ncbi.nlm.nih.gov/PMC9850959
https://doi.org/10.1016/j.ejmech.2019.03.015
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21651
https://portal.issn.org/resource/ISSN/0223-5234
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Neutral sphingomyelinase 2 inhibitors based on the 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol scaffold
discusses http://id.nlm.nih.gov/mesh/M0016520
http://id.nlm.nih.gov/mesh/M0007520
http://id.nlm.nih.gov/mesh/M0095023
http://id.nlm.nih.gov/mesh/M0020300
http://id.nlm.nih.gov/mesh/M0011048
http://id.nlm.nih.gov/mesh/M0467887
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D010636Q000737
http://id.nlm.nih.gov/mesh/D010636Q000494
http://id.nlm.nih.gov/mesh/D004791Q000737
http://id.nlm.nih.gov/mesh/D004791Q000494
http://id.nlm.nih.gov/mesh/D007093Q000737
http://id.nlm.nih.gov/mesh/D013108Q000037
http://id.nlm.nih.gov/mesh/D007093Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D010636Q000378
http://id.nlm.nih.gov/mesh/D013108Q000378
http://id.nlm.nih.gov/mesh/D007093Q000493
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004791Q000378
http://id.nlm.nih.gov/mesh/D004791Q000493
http://id.nlm.nih.gov/mesh/D010636Q000493
http://id.nlm.nih.gov/mesh/D008862Q000378
http://id.nlm.nih.gov/mesh/D007093Q000378
http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8638
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f04dd3ff111bb96d52c806aaa66e89e2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1131802
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281877

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID94338
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID55512

Showing number of triples: 1 to 66 of 66.